Pregnant women with high/low BMI are at higher risk of complications and hospital admissions

The study was carried out in collaboration between researchers at the Universities of Edinburgh and Aberdeen, and the Information Services Division of NHS Scotland.

It used routine obstetric records in Scotland, between 2003-2010, to investigate the impact of pregnant women's BMI on clinical complications, the number and duration of hospital admissions and short-term healthcare costs to the NHS.

The 109,592 pregnant women examined in the study were classed in five BMI categories, underweight (BMI 35).

Data from the analysis showed that the risk of maternal complications increased with BMI and, when compared to normal weight women, severely obese women had a three-fold increased risk of hypertension (2.6% vs 7.8%) and gestational diabetes (0.1% vs 3%).

Furthermore, when compared to normal weight women, all other weight categories showed an increase in the duration and number of maternal hospital admissions required after the birth. Underweight women had an 8% increased risk for admission, while overweight, obese and severely obese women's risk grew substantially more, 16%, 45% and 88% respectively.

The additional maternity costs, for women with high or low BMI, were also higher when compared to the standard maternal health service cost for women of normal weight. The estimated additional cost for underweight women was £102.3, overweight women £59.9, obese women £202.5 and severely obese women £350.8.

Dr Fiona Denison, Tommy's Centre for Maternal and Fetal Health, MRC Centre for Reproductive Health, Queens's Medical Research Institute Edinburgh and co-author of the paper, said:

“Our data demonstrates that both high and low maternal BMI are associated with increased risk of complications during pregnancy, increased numbers and duration of maternal admissions and higher health service costs.

“These findings further highlight the need for local and national government in Scotland, and other developed countries, to implement fundamental strategies that will help reduce the prevalence of obesity.

“Longer term benefits of reducing maternal obesity will show improvements, not only in the health outcomes of mothers and their babies, but the workload and cost to current maternity services.”

Mike Marsh, BJOG deputy editor-in-chief, added:

“We know that maternal obesity is a major cause of ill health in pregnancy in the UK, significantly increasing the risk of adverse medical outcomes such as gestational diabetes, hypertensive disorders and admissions for specialist care.

“This study confirms these risks and in addition highlights the financial burden to the NHS of obesity in pregnancy.

“It is vital that women understand the importance of maintaining a healthy weight prior to conception to reduce the risk of future pregnancy complications, the need for specialist care and the resulting cost to the NHS.”

Media Contact

Caitlin Walsh EurekAlert!

More Information:

http://www.wiley.com

All latest news from the category: Studies and Analyses

innovations-report maintains a wealth of in-depth studies and analyses from a variety of subject areas including business and finance, medicine and pharmacology, ecology and the environment, energy, communications and media, transportation, work, family and leisure.

Back to home

Comments (0)

Write a comment

Newest articles

Distance learning can improve women’s access to vocational training as animal health care practitioners in Nepal. Image Credit: Heifer International

Hybrid Job Training Boosts Women’s Participation in Nepal

Globally, women’s workforce participation is about 25% lower than men’s, often due to barriers such as domestic responsibilities and cultural norms. Vocational training can increase employment opportunities, but women may…

CO2release increase under repeated drying-rewetting cycles (DWCs). Image Credit: Suzuki, Nagano et al., 2025 SOIL

Drying and Rewetting Cycles Boost Soil CO2 Emissions

Niigata, Japan – The amount of carbon dioxide (CO2) released by microbial decomposition of soil organic carbon on a global scale is approximately five times greater than the amount of…

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers. Oregon State's Olena Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon Health & Science University, designed a type of drug nanocarrier known as a polymersome to specifically target a protein in choriocarcinoma cells. Depicted is a polymersome with its methotrexate cargo. Illustration by Parinaz Ghanbari. Image Credit: Parinaz Ghanbari

Improved Treatment Method for Rare Pregnancy-Related Cancer

PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other…